anaplasia

(redirected from anaplastic)
Also found in: Dictionary, Thesaurus, Medical.

anaplasia

[‚an·ə′plāzh·ə]
(medicine)
Reversion of cells to an embryonic, immature, or undifferentiated state; degree usually corresponds to malignancy of a tumor.
Mentioned in ?
References in periodicals archive ?
"Anaplastic lymphoma is a kind of cancer that results in the abnormal build-up of T-cells in the lymph nodes," he added.
The cases with the best survival rates were diagnosed with oligodendrogliomas, and the cases with the worst survival were diagnosed with A, anaplastic astrocytoma, and anaplastic oligodendrogliomas (Figure 7).
Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Etude des Lymphomes de l'Adulte Trials.
Malignant peritoneal mesothelioma deciduoid or anaplastic variant?: point to ponder.
In 2017 Hacisalihogluet al., followed through with a retrospective analysis of 41 anaplastic OD cases, 35 patients received standard radiotherapy whilst 26 patients then underwent additional chemotherapy with temozolomide.2 In the 19 patients who had chromosomal 1p/19 co-deletion, progression free survival was noted to be significantly higher, regardless of treatment modality.
In this classification scheme, oligodendrogliomas are divided into two forms: the well-differentiated oligodendroglioma and the less common anaplastic oligodendroglioma.
(3) investigated the molecular profile of a recurrent ovarian mucinous tumor with a mural nodule of anaplastic carcinoma.
However, it is difficult to make an exact diagnosis of LMS before surgery and to distinguish it from anaplastic thyroid cancer, especially the spindle-cell variant of anaplastic thyroid cancer.
The diagnosis of anaplastic meningioma involving the spinal cord with extra neural metastasis of the present study was obtained through the clinical, histopathological and IHC findings.
Public health company The US Food and Drug Administration Friday approved Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of anaplastic thyroid cancer (ATC), a rare, aggressive type of thyroid cancer that accounts for about 1 to 2% of all thyroid cancers.
Tafinlar (dabrafenib) and Mekinist (trametinib) combined have been approved to treat anaplastic thyroid cancer caused by an abnormal BRAF V600E gene, the agency said Friday in a news release.
Few PXA can show increased mitoses with >5 / 10 High Power Field (HPF) along with necrosis which are termed as PXA with Anaplastic features.